Park Ha Biological Technology Co., Ltd.BYAH
Price (close)
$2.77
Market cap
—
P/E
—
Revenue (FY)
$2.5M
Net income
-$24.4M
Dividend yield
—
1-year total return
-98.5%
Net margin
-965.0%
Revenue growth
6.0%
Debt / equity
—
What Park Ha Biological Technology Co., Ltd. does.
business primarily consists of developing our private skincare label, direct skincare products sales and franchise alliances promotions.
Our “Park Ha” brand focuses on providing solutions for problematic skin. Established in 2016, the brand had its first store
launched in 2017. In addition to the five stores directly operated by Park Ha Jiangsu, as of October 31, 2025, 2024 and 2023, we had
Revenue and profit, by fiscal year.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | — | $1.9M | $2.5M | $2.4M | $2.5M |
| Net income | — | $191,298 | $852,042 | $478,561 | -$24.4M |
| Free cash flow | — | $1.4M | $103,861 | $874,901 | -$2,973 |
More on BYAH.
- Park Ha Biological Technology Co., Ltd. summary
- Park Ha Biological Technology Co., Ltd. financial statements
- Park Ha Biological Technology Co., Ltd. key metrics
- Park Ha Biological Technology Co., Ltd. health scores and style box
- Park Ha Biological Technology Co., Ltd. earnings
- Park Ha Biological Technology Co., Ltd. dividends
- Park Ha Biological Technology Co., Ltd. valuation
- Park Ha Biological Technology Co., Ltd. ownership and insiders
- Park Ha Biological Technology Co., Ltd. peers
Figures from Park Ha Biological Technology Co., Ltd.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.